The downregulation of C2ORF40 was found in various malignant tumors including esophageal tumor [6, 7], prostate tumor [8, 9], colorectal carcinoma [2] and breast cancer [5], and the lower expression of this gene was significantly correlated with worse survival rate [10, 11]. This evidence concerns the gene ECRG4 and breast cancer.